Related Experiment Video
Updated: Jun 26, 2026
07:49
Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
mitoEnergetics and cancer cell fate
Zhi Xiong Chen1, Rathiga Velaithan, Shazib Pervaiz
1Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Biochimica Et Biophysica Acta
|January 24, 2009
Summary
Mitochondria are crucial for cell fate, influencing survival, death, and cancer. Altered mitochondrial metabolism and energy (mitoenergetics) are key in cancer development and offer new therapeutic targets.
Area of Science:
- Cell Biology
- Biochemistry
- Oncology
Background:
- Mitochondria play a vital role in cell survival, growth, and death.
- Altered mitochondrial physiology and energy metabolism (mitoenergetics) are linked to pathological conditions, especially cancer.
- Cancer cells exhibit metabolic reprogramming, with increased nutrient uptake and a pro-oxidant intracellular environment.
Purpose of the Study:
- To explore the association between altered mitochondrial metabolism and cancer development.
- To highlight the role of mitochondria as a target in oncogenesis.
- To underscore the implications of metabolic re-circuiting and altered mitoenergetics for cancer therapy.
Main Methods:
- Review of existing literature on mitochondrial function in cell fate and cancer.
- Analysis of metabolic reprogramming in cancer cells.
- Examination of oncogene-induced carcinogenesis models, including Bcl-2 overexpression.
Main Results:
- Mitochondrial outer membrane permeabilization and altered mitoenergetics are critical in cell death.
- Metabolic reprogramming in cancer is tightly linked to mitoenergetics.
- Mitochondria are a key target in oncogene-induced carcinogenesis.
Conclusions:
- The reprogramming of cell metabolism and altered mitoenergetics are integral to cancer development and progression.
- Understanding these mitochondrial alterations represents a paradigm shift in cancer research.
- These findings have significant implications for developing novel cancer therapeutic strategies.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...